论文部分内容阅读
本文检测了42例肿瘤病人的红细胞C_3b受体活性变化及人胎胸腺素(HET)对其影响,以便为HET防治肿瘤提供理论依据。 1.材料与方法:42例为病理确诊的胃癌、肺癌、前列腺癌病人,男31例、女11例,平均年龄56.43±11.2岁。另以30例健康献血员为对照,男20例、女10例,平均年龄53.78±9.66岁。红细胞C_3b受体活性检测采用郭峰的方法[中华医学杂志1998;62(12):715〕。HET对C_3b受体活性的影响采用文献〔青岛医学院报1993;29(1):7 〕所介绍的方法检测。
This article examined the changes of erythrocyte C_3b receptor activity in 42 patients with cancer and the effect of human fetal thymosin (HET) on it in order to provide a theoretical basis for HET to prevent and treat cancer. 1.Materials and Methods: Forty-two patients with pathologically confirmed gastric cancer, lung cancer, and prostate cancer included 31 males and 11 females with an average age of 56.43±11.2 years. Another 30 healthy blood donors were used as controls. There were 20 males and 10 females with an average age of 53.78±9.66 years. Erythrocyte C3b receptor activity was detected by Guo Feng [Chinese Medical Journal 1998;62(12):715]. The effect of HET on C3b receptor activity was examined using the method described in the literature [Qingdao Medical College 1993;29(1):7].